Gene · 6184
Papers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning identifies disulfidptosis-related gene signature for pancreatic cancer prognosis and immune infiltration. | Discov Oncol | 2026 | 41591656 | PubTator, text mining | PubMed |
| Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation. | Angew Chem Int Ed Engl | 2026 | 41556619 | PubTator, text mining | PubMed |
| Design, synthesis, and antitumor activity of novel Flavokawain A derivatives by suppressing LRPPRC-YBX1-RPN1 cascade. | Bioorg Chem | 2026 | 41529605 | PubTator, text mining | PubMed |
| Letter to the Editor: Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studies. | Int J Surg | 2026 | 41186531 | PubTator, text mining | PubMed |
| Glycosylated IgG antibodies contribute to the recovery of haemorrhagic fever with renal syndrome patients. | Elife | 2025 | 41460167 | PubTator, text mining | PubMed |
| Activity of α1,6-fucosyltransferase (FUT8) is reduced by depletion of oligosaccharyltransferase subunits. | Glycobiology | 2025 | 41384752 | PubTator, text mining | PubMed |
| CERS6 promotes esophageal squamous cell carcinoma proliferation by increasing the stability of RPN1. | Cell Death Discov | 2025 | 41203639 | PubTator, text mining | PubMed |
| Oligosaccharyltransferase Is Involved in Targeting to ER-Associated Degradation. | Cells | 2025 | 41148808 | PubTator, text mining | PubMed |
| A chemoproteomic strategy for identifying protein covalent binding targets of clozapine: An approach for advancing clozapine toxicity research. | Toxicol Lett | 2025 | 41130544 | PubTator, text mining | PubMed |
| Intact glycopeptide-based N-glycoproteomic analysis reveals disease signatures of altered glycoforms and site-specific glycan modifications in hepatocellular carcinoma tissues. | Int J Biol Macromol | 2025 | 41125172 | PubTator, text mining | PubMed |
| Structural basis of K11/K48-branched ubiquitin chain recognition by the human 26S proteasome. | Nat Commun | 2025 | 41093839 | PubTator, text mining | PubMed |
| Bidirectional Regulatory Mechanisms of Disulfidptosis Govern Precision Targeting in Degenerative Bone Diseases and Osteosarcoma. | J Cell Physiol | 2025 | 41065052 | PubTator, text mining | PubMed |
| Bioinformatic analysis of brucellosis and construction of a diagnostic model based on key genes. | Sci Rep | 2025 | 41053229 | PubTator, text mining | PubMed |
| Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma. | Discov Oncol | 2025 | 41003892 | PubTator, text mining | PubMed |
| The dynamics of stomatal closure of Arabidopsis thaliana determined by terahertz spectroscopy and a water transport model. | Sci Rep | 2025 | 40987839 | PubTator, text mining | PubMed |
| Multi-View Clustering-Based Outlier Detection for Converter Transformer Multivariate Time-Series Data. | Sensors (Basel) | 2025 | 40942646 | PubTator, text mining | PubMed |
| CD99-mediated immunological synapse formation potentiates CAR-T cell function. | Nat Commun | 2025 | 40866332 | PubTator, text mining | PubMed |
| RPN1 Is Associated With Immunosuppression in Pan-Cancer and Affects the Malignant Phenotype of Tumor. | FASEB J | 2025 | 40857034 | PubTator, text mining | PubMed |
| Protein modifications by advanced glycation end products (AGEs) in human clear cell renal cell carcinoma. | J Transl Med | 2025 | 40813989 | PubTator, text mining | PubMed |
| Ethylene antagonizes ABA responses in stomatal movement and seed germination by upregulating ABI1 and ABI2 at both the transcript and protein levels. | Plant J | 2025 | 40811817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6184/papers?page=2